Contents & References of Investigating the status of periodontal indicators in HTLV-I infected people and comparing it with healthy people
List:
Persian abstract..1
Chapter one: review of texts and articles.2
Chapter two: methodology and materials.30
Chapter three: findings..38
Chapter four: discussion..51
Chapter five: conclusions and suggestions.57
Resources..60
English abstract..65
Source:
Reference:
Fatemi Kazem, Bani Hashem Rad Seyed Ali, Tohidi Mohammad, Hosseini Seyed Hossein. Investigating the relationship between periodontal disease and chronic obstructive pulmonary disease (COPD). Magazine of Mashhad Faculty of Dentistry, Fall 2018; 33(3 (series 70)): 241-246.
Zadeh Modares Shahrazad*, Amouiyan Babak, Bayat Mohd Saeed, Mohammadi Mansoura, Sheikhul Islami Fereshte, Sheikhul Islami Leila. Comparison of gum health in mothers with premature birth and mothers with full-term birth in Mahdieh Hospital, Tehran, in 2011-2018. Dental Journal (Tehran University of Medical Sciences) spring 2016; 20(1 (series 50)):53-58.
Faryal Taleghani, Sadeghian Saeed, Sadeghi Rukhsare, Darafshan Abdolreza. Investigating the relationship between periodontal diseases and ischemic heart disease. Dental Journal of the Islamic Society of Dentists Winter 1386 : 19 (4), 76-83.
Farid Hosseini Reza, Safai Bijan. Investigation of virology and seroepidemiology of HTLV-1 in Khorasan. Journal of the Faculty of Medicine, Mashhad University of Medical Sciences, 1371; 35(Supplement No. 39):58-61.
Safai B, Huang J, Boeri E, Farid R, Raafat J, Schutzer P. Prevalence of HTLV1 infection in Iran: A serological and genetic study. AIDS Research and Human Retroviruses 1996; 12(12): 1185-90. Gallo RC. History of the discoveries of the first human retroviruses: HTLV-1 and HTLV-2. Oncogene. 2005 Sep 5; 24(39):5926-30.
Sidi Y, Meytes D, Shohat B, Fenig E, Weisbort Y, Lee H, Pinkhas J, Rosenblatt JD. Adult T-cell lymphoma in Israeli patients of Iranian origin. Cancer. 1990 Feb 1; 65(3):590-3.
Gallo RC: Kyoto Workshop on some specific recent advances in human tumor virology. Cancer Res 1981, 41:4738-4739.
Achiron A, Pinhas-Hamiel O, Doll L, Djaldetti R, Chen A, Ziv I, Avni A, Frankel G, Melamed E, Shohat B. Spastic paraparesis associated with human T-lymphotropic virus type I: a clinical, serological, and genomic study in Iranian-born Mashhadi Jews. Ann Neurol. 1993 November; 34(5):5-670.
Farid Hosseini Reza, Parizadeh Mohammad Javad, Ghafari Javad, Miri Sara, Nasirian Ali, Rafat Panah Hoshang. Seroepidemiological study of HTLV-1 infection in Neishabur city. Mashhad University of Medical Sciences Faculty of Medicine Journal, No. 83, 1383: pp. 424-417.
Abbaszadegan MR, Gholamian M, Tabatabaee A, Farid R, Houshmand M. Abbaszadegan M. Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran. J Clin Microbiol2003. 41(6); 2593-5.
Arjmand B, Aghayan SH, Goodarzi P, Farzanekhah M, Mortazavi SM, Niknam MH, Jafarian A, Arjmand F, Jebellyfar S. Prevalence of human T lymphtropic virus (HTLV) among tissue donors in Iranian tissue bank. Cell Tissue Bank 2009; 79 (12): 1914-20.
Tavanai Sani A. Serologic prevalence of HTLV among blood donors in Mashhad (northeastern Iran). Arch Irn Med 2001; 4 (1): 25-26.
Toro C, Rodes B, Aguilera A, Caballero E, Benito R, Tuset C. Clinical impact of HTLV-1 infection in Spain, implications for public health and mandatory screening. J Acquir Immune Defic Syndr 2002; 30 (3): 366-8.
Anarki Mohammadi Mohammadreza, Sadeghipour Alireza, Vathouq Parvaneh, Noormohammadi Isa, Mir Natghi Amir Mehdi. Investigation of the prevalence of HTLV-1 virus in thalassemia patients receiving frequent blood transfusions in Tehran in 2013. Journal of Iran University of Medical Sciences, No. 47, Autumn 2014: pp. 24-19.
Pourkarim Mahmoodreza, Khamisipour Gholamreza, Hajiani Gholamreza, Tahmasbi Rahim, Ardeshir Devani Noushin. Seroepidemiological investigation of HTLV I/II infection in patients receiving frequent blood in Bushehr province in 2013. Khoon Quarterly, No. 4, Summer 2014: pp. 104-99.
Flemming TF.Periodontitis. Ann Periodontal. 1999; 4(1): 32-80.
Socransky SS, Haffajee AD, Goodson JM, Lindhe J. new concepts of destructive periodontal disease. J clin Periodontol, 1984; 11 (1): 21-32.
Papapanou PN. Risk assessments in the diagnosis and treatment of periodontal diseases. J DentJ Dent Educ, 1998; 62 (10): 822-39.
Newman M, Takei H, Klakkevold P, Carranza f. Carranza's clinical periodontology. 11th ed. Philadelphia. WB Sounder: 2011. PP: 160-165.
Geo. F. Brooks, Kareh C. Carro U, Janet S. Butel, Stephen A. morse. Jawetz, Melnick & Adelberg's Medical Microbiology. 24th edition. McGraw Hill LANGE: 2007. PP:428-51.
Contreras A, Slots J. Mammalian Viruses in human Periodontitis. Oral Microbial Immunol, 1996; 11(6): 381-6. Garlett. G p, Giozza. S P, Silveira. E M. Claudino. M, Santos. S B, Avila. MJ, et al. Association of Human T Lymphotropic Virus 1 Amplification of Periodontitis Severity With Altered Cytokine Expression in Response to a Standard Periodontopathogen Infection. Clin Infect Dis, (2010)50(3): 11-18
Nasser Sargolzaee, Arab Hamidreza, Examination of periodontium in patients with spastic paraparesis related to HTLV-I, Journal of Mashhad Faculty of Dentistry Fall and Winter 1385-241-246
Sargolzaee N, Arab HR, Moein Tghavi A, Radvar M, Evaluation of HTLV-1 in Human Subgingival Plaque of Seropositive Patients. Journal of dentistry, tehran university of medical sciences 2008: 5(30): 111-115.
Lins L, de Carvalho VJ, de Almeida Rego FF, Azevedo R, Kashima S, Gallazi VN. Oral health profile in patients infected with HTLV-1: Clinical findings, proviral load, and molecular analysis from HTLV-1 in saliva. J Med Virol. 2012 Sep;84(9):1428-36.
Martins FM, Casseb J, Penalva-de-Oliveira AC, de Paiva MF, Watanuki F, Ortega KL. Oral manifestations of human T-cell lymphotropic virus infection in adult patients from Brazil. Oral Dis. 2010 Mar;16(2):167-71.
Soto-Ramirez LE, Garcia-Vallejo F, Renjifo B, Vergara A, Borrero I, Marlink R. Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy. Viral Immunol. 1995;8(3):141-50.
Poetker SK, Porto AF, Giozza SP, Muniz AL, Caskey MF, Carvalho EM. Clinical manifestations in individuals with recent diagnosis of HTLV type I infection. J Clin Virol. 2011 May;51(1):54-8.
Caskey MF, Morgan DJ, Porto AF, et al. Clinical manifestations associated with HTLV type I infection: A cross-sectional study. AIDS Res Hum Retroviruses 2007; 23:365-371.
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77(12): 7415-9.
Wong F, Staal RC, Galb RC. Htuman T-lymphotropic retroviruses. Nature 1985; 317(3): 395-403.
Hinuma Y, Nagata K, Hanaka M, Nakai M, Matsumoto T, Kinoshita K, Shirakawa S. Adult T-Cell Leukemia: Antigen in an ATL Cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sc USA 1981; 78(10): 6476-80.
Gessain A, Brain F, Vernant J, Gout O, maurs L, Calendar A. Antibodies to human T Lympho tropic Virus type 1 in patients with tropical Spastis parparesis. Lancet 1985; 24(8452): 7-10.
Balttner WA, Kalyanaraman VS, Robbert Guroff M. The human Type-C retrovirus, HTLV1, in blacks from the Caribbean region and relationship to adult T-Cell leukemia/Lymphoma. Int J Cancer 1982; 30(3): 257-64.
Tajima K, Tominaga S, Kuroishi T. Geographical features and epidemiological approach to endemic T-Cell leukemia/Lymphoma in Japan. Jpn J Clin Oncol 1979; 9(3): 495-504.
Hujoel PP. Destructive periodontal disease and tobacco and cannabis smoking. JAMA. 2008 Feb 6; 299(5): 574-5.
Sznajder N, Carraro JJ, RugnaS, Sereday M.